74 related articles for article (PubMed ID: 2908239)
21. In-vitro activity of enoxacin, ofloxacin, norfloxacin and nalidixic acid.
Bauernfeind A; Ullmann U
J Antimicrob Chemother; 1984 Sep; 14 Suppl C():33-8. PubMed ID: 6238931
[TBL] [Abstract][Full Text] [Related]
22. Antibacterial activity of ofloxacin and other 4-quinolone derivatives: in-vitro and in-vivo comparison.
Chantot JF; Bryskier A
J Antimicrob Chemother; 1985 Oct; 16(4):475-84. PubMed ID: 3864775
[TBL] [Abstract][Full Text] [Related]
23. [Structure-activity relationships in the quinolone group: antibacterial activity of two new compounds (author's transl)].
Thibault M; Koumaré B; Soussy CJ; Duval J
Ann Microbiol (Paris); 1981; 132(3):267-81. PubMed ID: 6457546
[TBL] [Abstract][Full Text] [Related]
24. [Comparison of the antibacterial effects of ofloxacin, oxolinic acid and nalidixic acid].
Langsádl L; Menkyna R; Golier J; Silan L
Cesk Epidemiol Mikrobiol Imunol; 1988 Sep; 37(5):297-308. PubMed ID: 3197127
[No Abstract] [Full Text] [Related]
25. Study of the in vitro activity of norfloxacin and other drugs on amoxicillin-resistant uropathogenic isolates.
Piccolomini R; Allocati N; Catamo G
Chemioterapia; 1984 Jun; 3(3):167-72. PubMed ID: 6241505
[TBL] [Abstract][Full Text] [Related]
26. Antibacterial activity and pharmacokinetics in mice of two new derivatives of norfloxacin.
Balsari A; Dubini F; Stradi R; Riviera L
Chemioterapia; 1987 Jun; 6(2 Suppl):176-8. PubMed ID: 3509384
[No Abstract] [Full Text] [Related]
27. Enhancement of antibacterial activity of norfloxacin and ofloxacin in vitro by serum and experimental pleural exudates.
Miglioli PA; Sartore P; Gianfranceschi L; Lanzafame P; Berti T
J Chemother; 1989 Jul; 1(4 Suppl):140-1. PubMed ID: 16312342
[No Abstract] [Full Text] [Related]
28. The in-vitro activity of three long-acting cephalosporins against Bacteroides fragilis, Peptostreptococcus species and Clostridium perfringens.
Watt B; Naden MG
J Chemother; 1989 Jul; 1(4 Suppl):106-7. PubMed ID: 16312326
[No Abstract] [Full Text] [Related]
29. [Susceptibility of anaerobic bacteria to cefoxitin (author's transl)].
Freydière AM; Gille Y; Marcel JP; Vincent P
Sem Hop; 1980 Nov 18-25; 56(43-44):1793-5. PubMed ID: 6256880
[TBL] [Abstract][Full Text] [Related]
30. In vitro comparison of norfloxacin with nalidixic acid, cinoxacin and oxolinic acid.
Vuye A
Arzneimittelforschung; 1983; 33(12):1623-7. PubMed ID: 6230083
[TBL] [Abstract][Full Text] [Related]
31. [Comparative in vitro study of the activity of 5 quinolones against Acinetobacter calcoaceticus].
Joly-Guillou ML; Bergogne-Berezin E
Pathol Biol (Paris); 1985 May; 33(5):416-20. PubMed ID: 3162142
[TBL] [Abstract][Full Text] [Related]
32. In vitro studies of S-25930 and S-25932, two new 4-quinolones.
Piddock LJ; Andrews JM; Diver JM; Wise R
Eur J Clin Microbiol; 1986 Jun; 5(3):303-10. PubMed ID: 2943589
[TBL] [Abstract][Full Text] [Related]
33. In vitro antibacterial activity of irloxacin (E-3432) on clinical isolates.
Coll R; Esteve M; Moros M; Xicota MA; Parés J
Drugs Exp Clin Res; 1987; 13(2):75-7. PubMed ID: 3582134
[TBL] [Abstract][Full Text] [Related]
34. Antimicrobial activity of SMAP-29 against the Bacteroides fragilis group and clostridia.
Arzese A; Skerlavaj B; Tomasinsig L; Gennaro R; Zanetti M
J Antimicrob Chemother; 2003 Sep; 52(3):375-81. PubMed ID: 12917245
[TBL] [Abstract][Full Text] [Related]
35. Antibacterial activity after a single-dose of norfloxacin, ofloxacin and pipemidic acid detected in urine of volunteers.
Cruciani M; Monzillo V; Navarra A; Tinelli C; Concia E
Drugs Exp Clin Res; 1988; 14(8):533-7. PubMed ID: 3150350
[TBL] [Abstract][Full Text] [Related]
36. Comparative in vitro activity of ciprofloxacin and five other quinoline derivatives against gram-negative isolates.
Galante D; Pennucci C; Esposito S; Barba D
Drugs Exp Clin Res; 1985; 11(5):331-4. PubMed ID: 2941260
[TBL] [Abstract][Full Text] [Related]
37. The effect of nalidixic acid on microaerophilic and anaerobic bacteria. Special study of clostridia.
Cancet B
Zentralbl Bakteriol Orig A; 1979 Sep; 244(4):535-40. PubMed ID: 232341
[TBL] [Abstract][Full Text] [Related]
38. [Effect of norfloxacin on bacterial flora in human feces].
Motohiro T; Oda K; Aramaki M; Kawakami A; Tanaka K; Koga T; Shimada Y; Tomita S; Sakata Y; Fujimoto T
Jpn J Antibiot; 1987 Sep; 40(9):1584-616. PubMed ID: 3694785
[TBL] [Abstract][Full Text] [Related]
39. In vitro activity of S-ofloxacin.
Neu HC; Chin NX
Antimicrob Agents Chemother; 1989 Jul; 33(7):1105-7. PubMed ID: 2506805
[TBL] [Abstract][Full Text] [Related]
40. [Activity of norfloxacin against gram-negative bacteria].
Ben Redjeb S; Ennaifer M; Kechrid A; Ben Hassen A; Boujnah A
Tunis Med; 1989; 67(6-7):391-5. PubMed ID: 2508283
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
